E-LIB Suche - Ergebnisse für: Gloria Margiotta-Casaluci - Sprache DE

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

New Frontiers in Monoclonal Antibodies for Relapsed/Refract..:

Schipani, Mattia ; Rivolta, Giulia Maria ; Margiotta-Casaluci, Gloria...
Cancers. 16 (2023) 1 - p. 187 , 2023

Link: https://doi.org/10.3390/..

2

Cumulative radiation exposure from radiological imaging in ..:

Brambilla, Marco ; Matheoud, Roberta ; Margiotta-Casaluci, Gloria...
The British Journal of Radiology. 96 (2023) 1149 - p. , 2023

Link: https://doi.org/10.1259/..

3

P895: DARATUMUMAB PLUS POMALIDOMIDE AND DEXAMETHASONE (DPD)..:

Montefusco, Vittorio ; Maria Cafro, Anna ; Margiotta-Casaluci, Gloria...
HemaSphere. 7 (2023) S3 - p. e729785d , 2023

Link: https://doi.org/10.1097/..

4

Comparison of first-line treatment with bendamustine plus r..:

Margiotta-Casaluci, Gloria ; Bigliardi, Sara ; Cocito, Federica...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

5

P1680: HEALTH-RELATED QUALITY OF LIFE IN TRANSPLANT-INELIGI..:

D'agostino, Mattia ; Bringhen, Sara ; Giuliani, Nicola...
HemaSphere. 7 (2023) S3 - p. e993869a , 2023

Link: https://doi.org/10.1097/..

6

Early progression of disease predicts shorter survival in M..:

Annarita Conconi ; Catherine Thieblemont ; Luciano Cascione...
Haematologica. 105 (2020) 11 - p. 2592-2597 , 2020

Link: https://doi.org/10.3324/..

7

P895: DARATUMUMAB PLUS POMALIDOMIDE AND DEXAMETHASONE (DPD)..:

Vittorio Montefusco ; Anna Maria Cafro ; Gloria Margiotta-Casaluci...
http://journals.lww.com/10.1097/01.HS9.0000970484.72978.5d. , 2023

Link: https://doi.org/10.1097/..

8

Comparison of first-line treatment with bendamustine plus r..:

Gloria Margiotta-Casaluci ; Sara Bigliardi ; Federica Cocito...
https://www.frontiersin.org/articles/10.3389/fonc.2023.1120967/full. , 2023

Link: https://doi.org/10.3389/..

9

New Frontiers in Monoclonal Antibodies for Relapsed/Refract..:

Mattia Schipani ; Giulia Maria Rivolta ; Gloria Margiotta-Casaluci...
https://www.mdpi.com/2072-6694/16/1/187. , 2023

Link: https://doi.org/10.3390/..

10

P1680: HEALTH-RELATED QUALITY OF LIFE IN TRANSPLANT-INELIGI..:

Mattia D'agostino ; Sara Bringhen ; Nicola Giuliani...
http://journals.lww.com/10.1097/01.HS9.0000973592.99386.9a. , 2023

Link: https://doi.org/10.1097/..

11

Elotuzumab plus pomalidomide and dexamethasone in relapsed/..:

Martino, Enrica Antonia ; Palmieri, Salvatore ; Galli, Monica...
Hematological Oncology. 42 (2024) 4 - p. , 2024

Link: https://doi.org/10.1002/..

12

High rate of durable responses with undetectable minimal re..:

Mauro, Francesca R. ; Starza, Irene Della ; Messina, Monica...
Haematologica. 108 (2023) 8 - p. 2091-2100 , 2023

Link: https://doi.org/10.3324/..

13

P-109 Carfilzomib-lenalidomide-dexamethasone Vs. lenalidomi..:

D'Agostino, Mattia ; Antonioli, Elisabetta ; Gamberi, Barbara...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S94-S95 , 2023

Link: https://doi.org/10.1016/..

14

Elotuzumab plus pomalidomide and dexamethasone in relapsed/..:

Gentile, Massimo ; Vigna, Ernesto ; Palmieri, Salvatore...
Haematologica. , 2023

Link: https://doi.org/10.3324/..

15

Biological features and outcome of diffuse large B‐cell lym..:

Arcari, Annalisa ; Tabanelli, Valentina ; Merli, Francesco...
British Journal of Haematology. 201 (2023) 4 - p. 653-662 , 2023

Link: https://doi.org/10.1111/..

1-15